PPLPHARMA — Piramal Pharma (Mumbai) Share News
0.000.00%
Last trade - 00:00- IN₹262.00bn
- IN₹304.53bn
- IN₹88.69bn
Brief: Piramal Pharma Says Division Announces US Launch Of Chlorpromazine Hydrochloride For Injection
India's Piramal Pharma rises after JM Financial initiates with Street-high target price
Brief: Piramal Pharma Says Piramal Pharma Solutions Inc And VetDC, Inc Entered Into Settlement Agreement
India's Piramal Pharma gains on Q2 profit surge
Brief: Piramal Pharma Says Piramal Pharma Solutions Announces $80M Expansion Plan
India's Piramal Pharma gains after Jefferies raises target price
Brief: Piramal Pharma To Reduce GHG Emissions By 2030
India's Piramal Pharma surges to record high after block deals
Brief: Piramal Pharma To Sell Plot Of Land, Factory For About 90 Mln Rupees
Brief: Piramal Pharma To Enter Into Agreements With Clean Max Aero, Clean Max Enviro Energy Solutions
India's Piramal Pharma up after US FDA ends inspection at facility
India's Piramal Pharma up as USFDA inspection ends at US facility
Brief: Piramal Pharma Says US FDA Inspection At Piramal Pharma's Manufacturing Facility Located At Lexington, USA
India's Piramal Pharma gains after upbeat Q4 results
Brief: Piramal Pharma March-Quarter Consol Net PAT Rises
India's Piramal Pharma up after FDA closes inspection of US facility
Brief: Piramal Pharma Says Closure Of Us FDA Inspection At Piramal Pharma's Manufacturing Facility Located At Riverview, Usa
Consumer Products Division Has Announced Its Foray Into Men's Personal Grooming Category
India's Piramal Pharma gains on anti-dumping probe on import of key product